Phio Pharmaceuticals (PHIO) Enterprise Value (2016 - 2021)
Historic Enterprise Value for Phio Pharmaceuticals (PHIO) over the last 10 years, with Q3 2021 value amounting to -$26.5 million.
- Phio Pharmaceuticals' Enterprise Value fell 5680.93% to -$26.5 million in Q3 2021 from the same period last year, while for Sep 2021 it was -$26.5 million, marking a year-over-year decrease of 5680.93%. This contributed to the annual value of -$14.2 million for FY2020, which is 10395.19% down from last year.
- Per Phio Pharmaceuticals' latest filing, its Enterprise Value stood at -$26.5 million for Q3 2021, which was down 5680.93% from -$29.4 million recorded in Q2 2021.
- Over the past 5 years, Phio Pharmaceuticals' Enterprise Value peaked at -$2.7 million during Q1 2018, and registered a low of -$32.7 million during Q1 2021.
- In the last 5 years, Phio Pharmaceuticals' Enterprise Value had a median value of -$10.9 million in 2019 and averaged -$12.9 million.
- As far as peak fluctuations go, Phio Pharmaceuticals' Enterprise Value skyrocketed by 7397.35% in 2018, and later crashed by 38177.71% in 2019.
- Phio Pharmaceuticals' Enterprise Value (Quarter) stood at -$3.6 million in 2017, then tumbled by 311.15% to -$14.9 million in 2018, then soared by 53.22% to -$7.0 million in 2019, then tumbled by 103.95% to -$14.2 million in 2020, then plummeted by 86.25% to -$26.5 million in 2021.
- Its last three reported values are -$26.5 million in Q3 2021, -$29.4 million for Q2 2021, and -$32.7 million during Q1 2021.